Vaxcyte (PCVX) Net Income (2019 - 2026)
Vaxcyte (PCVX) reported Net Income of -$277.02 million for Q2 2026, compared with -$195.15 million a year earlier.
Analysis
Vaxcyte (PCVX) Net Income (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vaxcyte's Net Income came in at -$1.06 billion; for FY2025, it was -$803.96 million.
- By year, Net Income came in at -$459.55 million in FY2024, -$405.13 million in FY2023, -$223.9 million in FY2022 and -$103.33 million in FY2021.
- Five-year quarterly Net Income spans a low of -$319.24 million in Q1 2026 and a high of -$26.86 million in Q3 2021.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$319.24 million (Q1 2026), -$247.83 million (Q4 2025) and -$213.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.69 Bn | 1,103.27 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 616.29 Bn | 534.82 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 500.86 Bn | 473.97 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 366.77 Bn | 321.15 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 235.52 Bn | 190.92 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 190.49 Bn | 164.69 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Vaxcyte | 9.22 Bn | 2.72 Bn | - | -284.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -284.30 Mn |
| Mar 31, 2026 | -320.62 Mn |
| Dec 31, 2025 | -246.51 Mn |
| Sep 30, 2025 | -212.83 Mn |
| Jun 30, 2025 | -166.57 Mn |
| Mar 31, 2025 | -140.72 Mn |
| Dec 31, 2024 | -137.08 Mn |
| Sep 30, 2024 | -103.12 Mn |
| Jun 30, 2024 | -128.70 Mn |
| Mar 31, 2024 | -95.02 Mn |
| Dec 31, 2023 | -180.80 Mn |
| Sep 30, 2023 | -92.66 Mn |
| Jun 30, 2023 | -68.34 Mn |
| Mar 31, 2023 | -60.46 Mn |
| Dec 31, 2022 | -78.05 Mn |
| Sep 30, 2022 | -57.92 Mn |
| Jun 30, 2022 | -48.53 Mn |
| Mar 31, 2022 | -38.99 Mn |
| Dec 31, 2021 | -28.56 Mn |
| Sep 30, 2021 | -26.62 Mn |
API Access
Vaxcyte Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=PCVX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();